Institutional Manager · CIK 0001616824
BML Capital Management, LLC
ZIONSVILLE, IN · File #028-22948
Latest AUM
$115.7M
Positions
16
Top-10 Concentration
95.6%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | -3,057,526 | -$13.9M | $0 |
| NEW | CARMAX INC | KMX | +155,000 | +$6.0M | $0 |
| EXITED | ALUMIS INC | 022307102 | -1,210,415 | -$4.8M | $0 |
| EXITED | LAVA THERAPEUTICS NV | N51517105 | -1,970,610 | -$3.1M | $0 |
| ADD | TARGET CORP | TGT | +27,500 | +$2.7M | +$80,500 |
| REDUCE | CONNECT BIOPHARMA HLDGS LTD | CNTB | -858,613 | -$2.4M | +$1.7M |
| NEW | CARVANA CO | CVNA | +150 | +$2.0M | $0 |
| NEW | OUTSET MED INC | OM | +543,180 | +$2.0M | $0 |
| NEW | PLIANT THERAPEUTICS INC | PLRX | +1,546,137 | +$1.9M | $0 |
| EXITED | ATHIRA PHARMA INC | 04746L203 | -323,066 | -$1.3M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202516 pos · $115.7M
- 13F HOLDINGS REPORTQ/E Sep 202520 pos · $109.2M
- 13F HOLDINGS REPORTQ/E Jun 202524 pos · $132.2M
- 13F HOLDINGS REPORTQ/E Mar 202527 pos · $123.6M
- 13F HOLDINGS REPORTQ/E Dec 202425 pos · $161.0M
- 13F HOLDINGS REPORTQ/E Sep 202429 pos · $169.9M
- 13F HOLDINGS REPORTQ/E Jun 202428 pos · $140.1M
- 13F HOLDINGS REPORT (Amended)Q/E Mar 202432 pos · $151.7M
- 13F HOLDINGS REPORTQ/E Mar 202430 pos · $149.4M
- 13F HOLDINGS REPORTQ/E Dec 202326 pos · $108.9M
Top 16 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | ACRS | 14,250,000 | $42.9M | 37.08% |
| 2 | ATEA PHARMACEUTICALS INC | AVIR | 7,490,000 | $26.7M | 23.11% |
| 3 | ORAMED PHARMACEUTICALS INC | ORMP | 3,167,231 | $9.0M | 7.80% |
| 4 | INSTIL BIO INC | TIL | 645,600 | $7.1M | 6.14% |
| 5 | PMV PHARMACEUTICALS INC | PMVP | 5,292,000 | $6.6M | 5.72% |
| 6 | CARMAX INC | KMX | 155,000 | $6.0M | 5.18% |
| 7 | KEZAR LIFE SCIENCES INC | KZR | 720,787 | $4.5M | 3.92% |
| 8 | TARGET CORP | TGT | 37,500 | $3.7M | 3.17% |
| 9 | CARVANA CO | CVNA | 150 | $2.0M | 1.74% |
| 10 | OUTSET MED INC | OM | 543,180 | $2.0M | 1.74% |
| 11 | PLIANT THERAPEUTICS INC | PLRX | 1,546,137 | $1.9M | 1.63% |
| 12 | IMAGENEBIO INC | IMA | 177,026 | $1.2M | 1.06% |
| 13 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 408,887 | $1.2M | 1.00% |
| 14 | WALMART INC | WMT | 335 | $492,450 | 0.43% |
| 15 | TESLA INC | TSLA | 1,000 | $205,000 | 0.18% |
| 16 | LISATA THERAPEUTICS INC | LSTA | 73,348 | $136,427 | 0.12% |